Kissei Pharmaceutical Co Ltd -Licensing Agreement With Viridian Therapeutics For "Veligrotug" And "Vrdn-003" In Treatment Of Thyroid Eye Disease

TradingKey - When it comes to investing in today’s environment, characterised by uncertainty in the markets, fluctuating interest rates and fast-paced technological change, many investors are asking themselves if investing in a market-indexed fund like the VOO (Vanguard S&P 500 ETF) still provides t

TradingKey - By the end of 2025, growth will have outperformed value by a wide margin across all sectors. Even though 2025 started with strong performance for value stocks (for two years), many investors were concerned about the possibility of continuing to see high valuations for growth stocks. 

TradingKey - On March 20, 2026, gold prices are falling as rising oil prices have renewed fears about inflation. This has pushed up the US Dollar and bond yields, which is reducing demand for gold, even as tensions continue to rise.

TradingKey - Due to strong demand for high-performance computers, AMD's position in the semiconductor industry has been on fire, Strong demand has put an immense amount of pressure on AMD as it attempts to balance between the growth of new Data Centers and AI workloads

Most investors don’t spend much time thinking about helium. It’s the party-balloon gas… or at least that’s what most people think. But But behind the scenes, helium keeps a lot of high-end tech running - and supply has tightened fast lately.